TCMGX
Price
$22.13
Change
+$0.24 (+1.10%)
Updated
Oct 8 closing price
Net Assets
787.14M
VMGIX
Price
$116.86
Change
+$1.26 (+1.09%)
Updated
Oct 8 closing price
Net Assets
33.08B
Interact to see
Advertisement

TCMGX vs VMGIX

Header iconTCMGX vs VMGIX Comparison
Open Charts TCMGX vs VMGIXBanner chart's image
Nuveen Quant Mid Cap Growth A
Price$22.13
Change+$0.24 (+1.10%)
VolumeN/A
Net Assets787.14M
Vanguard Mid-Cap Growth Index Investor
Price$116.86
Change+$1.26 (+1.09%)
VolumeN/A
Net Assets33.08B
TCMGX vs VMGIX Comparison Chart in %
View a ticker or compare two or three
VS
TCMGX vs. VMGIX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCMGX is a Buy and VMGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 33.1B vs. TCMGX (787M). VMGIX pays higher dividends than TCMGX: VMGIX (0.50) vs TCMGX (0.00). TCMGX was incepted earlier than VMGIX: TCMGX (23 years) vs VMGIX (19 years). TCMGX (0.85) is less costly to investors than VMGIX (0.19). TCMGX is a more actively managed with annual turnover of: 47.00 vs. VMGIX (21.00). TCMGX has a lower initial minimum investment than VMGIX: TCMGX (2500) vs VMGIX (3000). VMGIX annual gain was more profitable for investors over the last year : 20.31 vs. TCMGX (12.95). VMGIX return over 5 years is better than : 56.01 vs. TCMGX (-14.46).
TCMGXVMGIXTCMGX / VMGIX
Total Expense Ratio0.850.19447%
Annual Report Gross Expense Ratio0.850.19447%
Fund Existence23 years19 years-
Gain YTD7.83315.87549%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets787M33.1B2%
Annual Yield % from dividends0.000.50-
Returns for 1 year12.9520.3164%
Returns for 3 years44.2068.3165%
Returns for 5 years-14.4656.01-26%
Returns for 10 years5.90192.303%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOLV72.430.27
+0.37%
Solventum Corp
INBX33.610.11
+0.33%
Inhibrx Biosciences Inc.
INCR1.61N/A
-0.31%
Intercure Ltd
EYE27.54-0.26
-0.94%
National Vision Holdings
UGRO0.40-0.01
-3.30%
urban-gro